Key terms
About CTMX
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CTMX news
Apr 22
4:39am ET
CytomX Therapeutics upgraded to Neutral from Underweight at JPMorgan
Apr 22
4:20am ET
Analysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (CYTH), CytomX Therapeutics (CTMX) and Pacific Biosciences (PACB)
Apr 08
8:06am ET
CytomX Therapeutics doses first patient in CX-2051 Phase 1 study
Apr 03
8:19am ET
CytomX announces $5M milestone triggered in Astellas Pharma TCB collaboration
Mar 25
6:17am ET
CytomX Therapeutics: A Balanced Hold Rating Amidst Financial Uncertainty and Clinical Progress
Mar 22
4:23pm ET
CytomX Therapeutics Welcomes New Director and Updates Bylaws
Mar 21
8:10am ET
CytomX Therapeutics appoints Zhen Su to board of directors
Mar 18
8:08am ET
CytomX Therapeutics announces milestone achievement in PROBODY TCB
Mar 13
2:02am ET
CytomX Therapeutics Braces for Increased Compliance Costs as it Outgrows ‘Smaller Company’ Status
Mar 12
8:20am ET
Analysts Conflicted on These Healthcare Names: Insmed (INSM), Oric Pharmaceuticals (ORIC) and CytomX Therapeutics (CTMX)
Mar 12
7:29am ET
CytomX Therapeutics price target lowered to $3.25 from $3.30 at BMO Capital
Mar 12
7:10am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN) and CytomX Therapeutics (CTMX)
Mar 12
6:05am ET
J.P. Morgan Keeps Their Sell Rating on CytomX Therapeutics (CTMX)
Mar 12
4:41am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN), ACADIA Pharmaceuticals (ACAD) and CytomX Therapeutics (CTMX)
Mar 11
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 11, 2024
Mar 01
11:04am ET
Biotech Alert: Searches spiking for these stocks today
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Jan 24
8:04am ET
CytomX Therapeutics announces FDA clearance of IND applications for CX-2051
No recent press releases are available for CTMX
CTMX Financials
Key terms
Ad Feedback
CTMX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CTMX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range